Literature DB >> 32200557

Japanese Clinical Practice Guidelines for Vascular Anomalies 2017.

Hidefumi Mimura1, Sadanori Akita2, Akihiro Fujino3, Masatoshi Jinnin4, Mine Ozaki5, Keigo Osuga6, Hiroki Nakaoka7, Eiichi Morii8, Akira Kuramochi9, Yoko Aoki10, Yasunori Arai1, Noriko Aramaki11, Masanori Inoue12, Yuki Iwashina5, Tadashi Iwanaka13, Shigeru Ueno14, Akihiro Umezawa15, Michio Ozeki16, Junko Ochi17, Yoshiaki Kinoshita18, Masakazu Kurita19, Shien Seike20, Nobuyuki Takakura21, Masataka Takahashi15, Takao Tachibana22, Kumiko Chuman23, Shuji Nagata24, Mitsunaga Narushima25, Yasunari Niimi26, Shunsuke Nosaka27, Taiki Nozaki28, Kazuki Hashimoto1, Ayato Hayashi29, Satoshi Hirakawa30, Atsuko Fujikawa1, Yumiko Hori8, Kentaro Matsuoka31, Hideki Mori7, Yuki Yamamoto4, Shunsuke Yuzuriha32, Naoaki Rikihisa33, Shoji Watanabe34, Shinichi Watanabe35, Tatsuo Kuroda36, Shunsuke Sugawara37, Kosuke Ishikawa38, Satoru Sasaki39.   

Abstract

The objective was to prepare guidelines to perform the current optimum treatment by organizing effective and efficient treatments of hemangiomas and vascular malformations, confirming the safety and systematizing treatment, employing evidence-based medicine techniques and aimed at improvement of the outcomes. Clinical questions (CQ) were decided based on the important clinical issues. For document retrieval, key words for published work searches were set for each CQ, and work published from 1980 to the end of September 2014 was searched in PubMed, Cochrane Library and Japana Centra Revuo Medicina databases. The strengths of evidence and recommendations acquired by systematic reviews were determined following the Medical Information Network Distribution System technique. A total of 33 CQ were used to compile recommendations and the subjects included efficacy of resection, sclerotherapy/embolization, drug therapy, laser therapy, radiotherapy and other conservative treatment, differences in appropriate treatment due to the location of lesions and among symptoms, appropriate timing of treatment and tests, and pathological diagnosis deciding the diagnosis. Thus, the Japanese Clinical Practice Guidelines for Vascular Anomalies 2017 have been prepared as the evidence-based guidelines for the management of vascular anomalies. This article has been co-published with the permission of The Journal of Dermatology, Pediatrics International and Japanese Journal of Radiology. All rights reserved.
© 2020 The Authors. The articles are identical except for minor stylistic and spelling differences in keeping with each journal’s style. Either citation can be used when citing this article.

Entities:  

Keywords:  clinical practice; guidelines; hemangioma; vascular anomalies; vascular malformation

Mesh:

Year:  2020        PMID: 32200557      PMCID: PMC7317503          DOI: 10.1111/1346-8138.15189

Source DB:  PubMed          Journal:  J Dermatol        ISSN: 0385-2407            Impact factor:   4.005


  350 in total

1.  Dye laser treatment of port-wine stains.

Authors:  Y Bandoh; A Yanai; K Tsuzuki
Journal:  Aesthetic Plast Surg       Date:  1990       Impact factor: 2.326

2.  Refractory congenital chylous ascites.

Authors:  Antônio Aldo Melo-Filho; Ivana Jesus Nogueira Souza; Christiane Araújo Chaves Leite; Robério Dias Leite; João Henrique Freitas Colares; Júlio Marcus Sousa Correia
Journal:  Indian J Pediatr       Date:  2010-09-07       Impact factor: 1.967

3.  Diffuse neonatal abdominal lymphangiomatosis: management by limited surgical excision and sclerotherapy.

Authors:  B Haluk Güvenç; Gülşen Ekingen; Ayşe Tuzlaci; Ufuk Senel
Journal:  Pediatr Surg Int       Date:  2005-06-02       Impact factor: 1.827

4.  Use of the radial forearm artery for secondary embolization of an extensive life-threatening arteriovenous malformation of the mid-face and anterior skull base - a case report.

Authors:  Michael A Ermer; Ralf Gutwald; Martin Schumacher; Rainer Schmelzeisen; Christian Taschner
Journal:  J Craniomaxillofac Surg       Date:  2012-12-14       Impact factor: 2.078

5.  Use of propranolol for the treatment infantile hemangiomas in the maxillofacial region.

Authors:  R R Sadykov; F Podmelle; R A Sadykov; K R Kasimova; H R Metellmann
Journal:  Int J Oral Maxillofac Surg       Date:  2013-04-22       Impact factor: 2.789

6.  Response of ulcerated perineal hemangiomas of infancy to becaplermin gel, a recombinant human platelet-derived growth factor.

Authors:  Brandie J Metz; Melissa C Rubenstein; Moise L Levy; Denise W Metry
Journal:  Arch Dermatol       Date:  2004-07

7.  Multicenter prospective study of ulcerated hemangiomas.

Authors:  Sarah L Chamlin; Anita N Haggstrom; Beth A Drolet; Eulalia Baselga; Ilona J Frieden; Maria C Garzon; Kimberly A Horii; Anne W Lucky; Denise W Metry; Brandon Newell; Amy Jo Nopper; Anthony J Mancini
Journal:  J Pediatr       Date:  2007-08-24       Impact factor: 4.406

8.  Involution of infantile haemangiomas after imiquimod 5% cream.

Authors:  R B M Barry; B R Hughes; L J Cook
Journal:  Clin Exp Dermatol       Date:  2008-05-15       Impact factor: 3.470

9.  GLUT1 endothelial reactivity distinguishes hepatic infantile hemangioma from congenital hepatic vascular malformation with associated capillary proliferation.

Authors:  Jun Q Mo; Haytham H Dimashkieh; Kevin E Bove
Journal:  Hum Pathol       Date:  2004-02       Impact factor: 3.466

10.  Treatment of venous malformations with sclerosant in microfoam form.

Authors:  Juan Cabrera; Juan Cabrera; Ma Antonia Garcia-Olmedo; Pedro Redondo
Journal:  Arch Dermatol       Date:  2003-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.